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A 61-year-old female was referred to our hospital presenting with micturition pain and urinary
frequency, which was not relieved by antibiotics. A cystoscopic examination revealed an erosion, reddening
and edematous lesion in the left bladder wall. Pathological examination of transurethral biopsy showed
erosion and cystitis. After biopsy, micturition pain and urinary frequency became worse. The pathological
examination was reviewed, and the diagnosis of eosinophilic cystitis was made. Administration of a
corticosteroid had provided a short duration of relief, but her symptoms recurred within the ﬁve weeks of
treatment. Therefore, she was treated with a combination of corticosteroid and suplatast tolilate, followed
by monotherapy with suplatast tolilate. The relief of the symptoms by suplatast tolilate therapy continued
for ﬁve months. However, the symptoms relapsed. Re-administration of steroidal agents was considered,
but the patient suffered from uncontrolled diabetes. Therefore, she was treated with a combination of
suplatast tosilate, anti-allergic drugs and mirabegron. Fourteen months after treatment with suplatast
tosilate, no disease progression was noted.
(Hinyokika Kiyo 60 : 447-450, 2014)









患 者 : 61歳，女性
主 訴 : 頻尿，残尿感
既往歴 : 糖尿病（インスリン皮下注），花粉症





初診時現症 : 身長 161 cm，体重 75.3 kg．
理学的・神経学的異常所見なし．表在リンパ節触知
せず．
初診時検査所見 : 血液一般では WBC 6,900/μl，好
酸球分画4.8％と正常範囲内で，その他明らかな異常
所見は認めなかった．HbA1c は7.9％と高値であっ
た．尿検査 ; 蛋白（2＋），糖（3＋），RBC 10∼19/
HPF，WBC ≧100/HPF．尿培養 ; 酵母様真菌 104/
ml，コアグラーゼ陰性ブドウ球菌 103/ml．尿細胞診











中 IgE を測定したところ 6,792 IU/ml と著明高値で
あった (IgE 正常範囲 ＜100 IU/ml）．病理組織を見直
したところ，好酸球浸潤の目立つ箇所を複数認め，好
酸球性膀胱炎の診断となった (Fig. 3）．
治療経過 (Fig. 4) : 好酸球性膀胱炎と診断がつくま
では，膀胱刺激症状に対しプロピベリン塩酸塩 20
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Fig. 1. MRI showed diffuse thickness of the left
bladder wall.
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Fig. 2. A cystoscopic examination showed erosion,
reddening and edematous lesion in the left
bladder wall.
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Fig. 3. Microscopic appearance of the bladder wall.
Inﬂammatory inﬁltration containing eosino-
phils and edema could be noted in the




スチン 20 mg/日を投与した．プレドニゾロンは 30
mg/日より開始し，徐々に漸減していった．膀胱容量







10 mg/日のままで，トシル酸スプラタスト 300 mg/日
の内服併用を開始した．その後，症状改善が見られた
のでプレドニゾロンを徐々に減量し中止することがで



















5 を産生・分泌していることから autocrine により活
性化された好酸球が細胞障害性蛋白を産生することに
より引き起こされていると考えられている3)．
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Fig. 4. Clinical course of the patient, showing changes in serum IgE.
泌60,09,08-5
Fig. 5. Follow-up cystoscopic examination showed
improvement of erosion, reddening and


















































し IL-4，5 の産生を選択的に抑制する．IL-4 抑制によ
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